Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., ...Daha Fazla

JOURNAL OF RHEUMATOLOGY, cilt.32, sa.1, ss.98-105, 2005 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 1
  • Basım Tarihi: 2005
  • Dergi Adı: JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.98-105
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective. To determine the effect of the tumor necrosis factor-a blocker-etanercept on the pathergy and monosodium urate (MSU) status and on the mucocutaneous and articular manifestations of patients with Behcet's disease (BD).